Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

MIRA Pharmaceuticals Announced New Insights Garnered From Additional, Recently Received Preclinical Study Data Regarding The Mechanism Of Action And Toxicology Data For Its Oral Ketamine Analog, Ketamir-2

Author: Benzinga Newsdesk | July 25, 2024 07:19am

Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog.

Posted In: MIRA